Over 90 Total Lots Up For Auction at One Location - WA 04/08

Bloodbuy wins prestigious Harvard Forum on Healthcare innovation award

Press releases may be edited for formatting or style | April 27, 2016
April 08, 2016, BOSTON—Bloodbuy, the Dallas-based company whose technology connects hospitals and blood centers nationwide to ensure the efficient flow of lifesaving blood products to patients in need, has been named the winner of the first Harvard Business School-Harvard Medical School Health Acceleration Challenge.

“This award is obviously a huge honor, and our team is blown away,” commented Christopher Godfrey, founder and CEO of Bloodbuy. “It serves as tremendous validation for the work we are doing to try to create a higher level of efficiency in what we consider one of the most critical health care verticals.”

The Health Acceleration Challenge is a “scale up” competition that focuses on compelling, already-implemented health care solutions and helps them to grow and increase their impact through powerful networking and funding opportunities. In its first year, the Health Acceleration Challenge received 478 applicants and attracted 20,000 online visitors from 29 countries.
stats
DOTmed text ad

Reveal Mobi Pro now available for sale in the US

Reveal Mobi Pro integrates the Reveal 35C detector with SpectralDR technology into a modern mobile X-ray solution. Mobi Pro allows for simultaneous acquisition of conventional & dual-energy images with a single exposure. Contact us for a demo at no cost.

stats
“Bloodbuy’s innovation addresses a significant problem in health care—the imbalance between the supply of and demand for blood,” said Robert S. Huckman, the Albert J. Weatherhead III Professor of Business Administration at Harvard Business School. "Its online platform and ability to scale its organization have already had a positive impact on patient care, and the company is poised to make even greater contributions in the future. We are proud to recognize Bloodbuy's success with this award.”

Bloodbuy emerged as the winner after a year-long selection process that involved 18 semifinalists and then 4 finalists who shared in a $150,000 prize endowed by Howard E. Cox, Jr. (MBA 1969), now an advisory partner in the venture capital firm Greylock Partners and a member of both the HBS Healthcare Initiative Advisory Board and the Harvard Medical School Board of Fellows. As the final winner, Bloodbuy will receive an additional $50,000.

The other three finalists included Twine Health, Medalogix, and I-PASS. All the finalists showed strong results and continued innovation throughout the year, making it a very close competition.

Starting today the Forum on Health Care Innovation is accepting entries for the 2016 Health Acceleration Challenge. What proven innovations have you created that would enhance health care value in the U.S. if broadly disseminated? To learn more or to submit your innovation, please visitwww.healthaccelerationchallenge.com.

ABOUT THE HBS-HMS FORUM ON HEALTH CARE INNOVATION

You Must Be Logged In To Post A Comment